 MOUNTAIN VIEW, Calif., Aug. 01, 2022 GLOBE NEWSWIRE -- Iridex Corporation NASDAQ: IRIX, a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal diseases, today announced the Company will release financial results for the second quarter of 2022 after the close of trading on Monday, August 15, 2022. The Companys management team will host a corresponding conference call beginning at 2:00 p.m. PT 5:00 p.m. ET. 